Sunshine Act has very low thresholds for reporting pharma-doc ties

05/28/2013 | OncLive

The thresholds have been set quite low for reporting financial relationships between doctors and drugmakers under the Sunshine Act, Dr. Andrew L. Pecora writes. A line-item breakdown must be provided of any transfer of value exceeding $10 at a time, or $100 for a year. "Think about it: a glass of wine is not a problem; add a crab cake, however, and your name is listed on a national database. The real question is, why were the thresholds for reporting set so low?" Pecora writes.

View Full Article in:

OncLive

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA